EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 51 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15,578 | -56.7% | 51,075 | 0.0% | 0.00% | -100.0% |
Q2 2023 | $35,957 | -21.5% | 51,075 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $45,809 | -24.0% | 51,075 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $60,269 | -88.8% | 51,075 | -28.6% | 0.00% | -90.9% |
Q3 2022 | $539,000 | +36.8% | 71,575 | +14.4% | 0.01% | +57.1% |
Q2 2022 | $394,000 | -23.2% | 62,575 | +1.3% | 0.01% | -12.5% |
Q1 2022 | $513,000 | +67.1% | 61,775 | +4.6% | 0.01% | +100.0% |
Q4 2021 | $307,000 | -21.3% | 59,075 | +1.3% | 0.00% | -33.3% |
Q3 2021 | $390,000 | -11.8% | 58,325 | +12.3% | 0.01% | 0.0% |
Q2 2021 | $442,000 | -5.6% | 51,925 | -1.9% | 0.01% | -14.3% |
Q1 2021 | $468,000 | -41.4% | 52,925 | -18.5% | 0.01% | -46.2% |
Q4 2020 | $798,000 | +39.8% | 64,925 | -7.5% | 0.01% | +18.2% |
Q3 2020 | $571,000 | -4.0% | 70,175 | +13.2% | 0.01% | -8.3% |
Q2 2020 | $595,000 | +53.0% | 61,975 | +8.3% | 0.01% | +20.0% |
Q1 2020 | $389,000 | -48.7% | 57,225 | +12.5% | 0.01% | -9.1% |
Q4 2019 | $758,000 | +104.3% | 50,875 | +40.6% | 0.01% | +120.0% |
Q3 2019 | $371,000 | +2.2% | 36,175 | +5.6% | 0.01% | 0.0% |
Q2 2019 | $363,000 | +9.3% | 34,250 | +44.2% | 0.01% | +25.0% |
Q1 2019 | $332,000 | +23.9% | 23,750 | -9.9% | 0.00% | 0.0% |
Q4 2018 | $268,000 | +32.0% | 26,350 | +55.9% | 0.00% | +33.3% |
Q3 2018 | $203,000 | – | 16,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Telemetry Investments, L.L.C. | 135,848 | $2,024,000 | 6.74% |
INTERWEST VENTURE MANAGEMENT CO | 764,918 | $11,397,000 | 4.91% |
Knoll Capital Management, LLC | 350,238 | $5,219,000 | 3.85% |
683 Capital Management, LLC | 1,850,000 | $27,565,000 | 3.15% |
Soleus Capital Management, L.P. | 205,407 | $3,060,000 | 2.95% |
Broadfin Capital, LLC | 1,236,368 | $18,422,000 | 2.47% |
P.A.W. CAPITAL CORP | 144,000 | $2,146,000 | 2.29% |
MANGROVE PARTNERS IM, LLC | 847,284 | $12,625,000 | 1.85% |
Corriente Advisors, LLC | 203,898 | $3,038,000 | 1.63% |
Trellus Management Company, LLC | 63,850 | $951,000 | 1.59% |